Pediatric Cannabis Treatment for Behavioral Crises
Discover how pediatric cannabis treatment can be an effective option for managing behavioral crises in children.
Most doctors do not support medical cannabis for children as a general treatment. They do support one FDA-approved cannabidiol (CBD) product, Epidiolex, for three rare and severe epilepsy conditions in patients age 1 and older. For other conditions, pediatric groups say the evidence is too thin and the risks to a developing brain are too high for routine use.
The American Academy of Pediatrics (AAP) opposes recreational marijuana use by children and teens. It supports more research into medical cannabinoids and recognizes that some children with hard-to-treat epilepsy may benefit from CBD. The group does not endorse smoked or vaped cannabis, THC products, or homemade oils for children.
Conditions That Qualify for Pediatric Medical Cannabis
The FDA has approved only one cannabis-derived drug for children: Epidiolex. It contains purified CBD and is prescribed for seizures linked to Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. The FDA has not approved raw cannabis, THC gummies, or CBD sold at dispensaries for any pediatric condition.
Can Pediatric Patients Take THC Oil Safely? A Parent Guide
Dravet syndrome and Lennox-Gastaut syndrome have the most data. Clinical trials of Epidiolex showed fewer seizures in some children, which led to FDA approval. Tuberous sclerosis complex also has trial data strong enough for approval.
For other uses, evidence is anecdotal. Parents sometimes report better sleep, less pain, or calmer behavior, but small studies and case reports cannot prove cause and effect. Doctors want randomized controlled trials before they recommend cannabis for autism, ADHD, anxiety, chronic pain, or cancer symptoms in children.
THC is the psychoactive compound in cannabis. It can impair memory, attention, and coordination, and these effects may last longer in young people. Regular teen use is linked to problems with learning, mental health, and motivation, though researchers still debate how much is cause and how much is correlation.
Children are not small adults. Their brains, livers, and bodies process drugs in different ways. Dosing is hard to control with flower, edibles, or tinctures because potency varies. Contamination with pesticides, heavy metals, or mold adds another risk that lab-tested medicine avoids.
A pediatric specialist, often a neurologist, reviews the child's diagnosis and failed treatments. The doctor looks for FDA-approved options first. If those fail, the family may enroll in a clinical trial or, in some states, a medical cannabis program.
In states with pediatric cannabis laws, a physician must certify the child as a patient. The doctor sets a dose, picks a product type, and schedules follow-ups. Parents must track seizures, side effects, and behavior.
This is medical oversight, not a dispensary run for candy or snacks.
Bring a list of all medicines and supplements. Some epilepsy drugs interact with CBD, so doses may need changes. Ask about liver tests and follow-up visits.
If a doctor promises a cure or sells products from their own office, seek a second opinion.
Some doctors do support cannabis for children in narrow cases. They may be neurologists in a research setting or physicians in states with pediatric access laws. Their support comes with strict rules: purified products, lab testing, and close follow-up.
Support is not the same as a free pass. Even doctors who prescribe cannabis-based medicine for children say it is a last-line option. They do not recommend it for common childhood issues like teething, colic, or mild anxiety.
Federal law still lists cannabis as a Schedule I drug, but many states have medical cannabis programs. Some allow minors with a parent's consent and a doctor's certification. Rules differ by state, and federal law creates conflicts for doctors and families.
Pediatricians can certify patients in some state programs, but they cannot prescribe cannabis like a normal drug. Only Epidiolex is FDA-approved and available by prescription. Other products are recommended or certified under state law.
Epidiolex is approved for patients age 1 and older. State programs set their own age limits. Many allow minors of any age with a caregiver, while a few require extra approvals for young children.
Doctors do not recommend store-bought CBD gummies for children. The dose is not controlled, and products may contain THC or impurities. CBD can also interact with seizure medicines and cause liver problems.
The doctor confirms the diagnosis, documents prior treatments, and certifies the patient if state law allows. They also set a starting dose and schedule check-ins. Parents handle dosing each day and record symptoms between visits.
Doctors support medical cannabis for children in a narrow lane: FDA-approved CBD for three severe epilepsy syndromes. Outside that lane, most pediatric groups want more research and warn about THC, dosing errors, and product safety. Parents should treat cannabis like any other drug and ask a pediatric specialist for guidance.